Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Bayly

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin CDaniel Guay, Christian Beaulieu, Jean-Francois Truchon, et al.
Journal of Chemical Information and Modeling|June 27, 2007
Comparison of topological, shape, and docking methods in virtual screeningGeorgia B McGaughey, Robert P Sheridan, Christopher I Bayly, et al.
Journal of Chemical Information and Modeling|January 24, 2007
Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter spaceMarwen Naïm, Sathesh Bhat, Kathryn N Rankin, et al.
The Journal of Physical Chemistry. B|August 1, 2024
Benchmarking Quantum Mechanical Levels of Theory for Valence Parametrization in Force FieldsPavan Kumar Behara, Hyesu Jang, Joshua T Horton, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitorsYongxin Han, André Giroux, John Colucci, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Solid phase synthesis of selective caspase-3 peptide inhibitorsErich L Grimm, Bruno Roy, Renee Aspiotis, et al.
Living Journal of Computational Molecular Science|November 16, 2022
Best practices for constructing, preparing, and evaluating protein-ligand binding affinity benchmarks [Article v0.1]David F Hahn, Christopher I Bayly, Hannah E Bruce Macdonald, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2007
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic coreJoël Robichaud, Christopher I Bayly, W Cameron Black, et al.
Journal of Chemical Theory and Computation|October 24, 2018
Escaping Atom Types in Force Fields Using Direct Chemical PerceptionDavid L Mobley, Caitlin C Bannan, Andrea Rizzi, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2008
Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitorYongxin Han, Michel Belley, Christopher I Bayly, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin CDaniel Guay, Christian Beaulieu, Jean-Francois Truchon, et al.
Journal of Chemical Information and Modeling|June 27, 2007
Comparison of topological, shape, and docking methods in virtual screeningGeorgia B McGaughey, Robert P Sheridan, Christopher I Bayly, et al.
Journal of Chemical Information and Modeling|January 24, 2007
Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter spaceMarwen Naïm, Sathesh Bhat, Kathryn N Rankin, et al.
The Journal of Physical Chemistry. B|August 1, 2024
Benchmarking Quantum Mechanical Levels of Theory for Valence Parametrization in Force FieldsPavan Kumar Behara, Hyesu Jang, Joshua T Horton, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitorsYongxin Han, André Giroux, John Colucci, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Solid phase synthesis of selective caspase-3 peptide inhibitorsErich L Grimm, Bruno Roy, Renee Aspiotis, et al.
Living Journal of Computational Molecular Science|November 16, 2022
Best practices for constructing, preparing, and evaluating protein-ligand binding affinity benchmarks [Article v0.1]David F Hahn, Christopher I Bayly, Hannah E Bruce Macdonald, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2007
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic coreJoël Robichaud, Christopher I Bayly, W Cameron Black, et al.
Journal of Chemical Theory and Computation|October 24, 2018
Escaping Atom Types in Force Fields Using Direct Chemical PerceptionDavid L Mobley, Caitlin C Bannan, Andrea Rizzi, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2008
Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitorYongxin Han, Michel Belley, Christopher I Bayly, et al.
Pageof 4